Community pharmacy services to optimise the use of medications for mental illness: a systematic review

Abstract

The objective of this systematic review was to evaluate the impact of pharmacist delivered community-based services to optimise the use of medications for mental illness. Twenty-two controlled (randomised and non-randomised) studies of pharmacists' interventions in community and residential aged care settings identified in international scientific literature were included for review. Papers were assessed for study design, service recipient, country of origin, intervention type, number of participating pharmacists, methodological quality and outcome measurement. Three studies showed that pharmacists' medication counselling and treatment monitoring can improve adherence to antidepressant medications among those commencing treatment when calculated using an intention-to-treat analysis. Four trials demonstrated that pharmacist conducted medication reviews may reduce the number of potentially inappropriate medications prescribed to those at high risk of medication misadventure. The results of this review provide some evidence that pharmacists can contribute to optimising the use of medications for mental illness in the community setting. However, more well designed studies are needed to assess the impact of pharmacists as members of community mental health teams and as providers of comprehensive medicines information to people with schizophrenia and bipolar disorder

Impact of pharmacist interventions on patients' adherence to antidepressants and patient-reported outcomes: a systematic review

“…This critical narrative review revealed a positive effect of pharmacist interventions on antidepressant medication adherence by patients. The findings of this study are consistent with those of other researchers 34. In addition to revealing a positive effect of pharmacists’ intervention; this review also substantiated claims of improved medication adherence among depressed people who were treated by antidepressant medications prescribed by community mental health teams in Australia 34…”

Perception of Community Pharmacists in Malaysia About Mental Healthcare and Barriers to Providing Pharmaceutical Care Services to Patients with Mental Disorders

“…With the move towards deinstitutionalizing mental health care and encouraging management in the community setting, community pharmacists (CPs) can play a bigger role by providing pharmaceutical care (PC) services. A systematic review found that PC services by CPs resulted in improved adherence, and reduced the number of inappropriate medications prescribed in patients with mental disorders (Bell et al 2005).…”

The contribution of Ghanaian pharmacists to mental healthcare: current practice and barriers

“…A retrospective chart review has indicated that duties performed by pharmacists in psychiatric settings can improve physician prescribing practices and enhance treatment outcomes [8]. These positive outcomes, associated with savings in drug acquisition costs could, theoretically, reduce the potential side effect burden of the psychotropic agents administered and could reduce the numbers of potentially inappropriate psychotropic medications prescribed for mental illness [9-11]. Pharmacists in the United Kingdom play a role at every stage of the patient's recovery, whether patients are being cared for in an acute setting or in the community.…”